| LONZA N | 599.20 / +0.67% |
| Date/Time | 01/22 / 17:30 |
| Chg. / Chg.(%) | 4.00 / +0.67% |
| Bid | 596.00 / 16 |
| Ask | - / 2 |
| Open | 592.20 |
| Previous Close | 595.20 |
| High | 599.40 |
| Low | 588.20 |
| Volume [CHF] | 114,711,253.00 |
| Volume [Units] | 192,630 |
| Price fixings | 7818 |
| ISIN | CH0013841017 |
| Security | LONN |
| Exchange | SIX Swiss Exchange |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 548.800 |  |
|
| SIX Swiss Ex.. | 599.20 | |
192,630 |
| London Inter.. | 599.26 | |
18,841 |
| Nasdaq Other.. | 680.7500 |  |
342 |
| Mexico | 13,537.55 | |
210 |
| TradeGate | 294.000 | 298 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
01/12/2021 / 15:05 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
01/08/2021 / 13:00 - GlobeNewswire - Arbor Biotechnologies and Lonza Enter into Gene Editing Technology Licensing Deal
12/23/2020 / 14:00 - GlobeNewswire - Recro Announces Executive Changes
12/16/2020 / 13:00 - GlobeNewswire - Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors
12/07/2020 / 22:05 - GlobeNewswire
Real-time